Member Info for Mozax

Views, I disagree that this will be at the mercy of the value of Crypto’s. The fact is they are here to stay, on dips investors will see value & buy ( or sign up to Argo) Either way, the subscription model is genius, and subscribers will ride the rollercoaster while Argo ratchet up subscribers & make a fortune.

The point is they are starting to pull in big contracts relative to their MCap. Expect more of the same. Dynamic little Company.

Now.

Is not aware of Argo yet, it launched in the dead of August & although on the main market is too small to attract attention yet. Fast forward just a few months IMO, once that subscription base starts growing & it won’t take long at all to reach 100K subscribers, that’s revenue $5 Million a month..... Then the market will notice!

Fast now. 162.5%

Trend on Crypto’s with potential huge rally into the autumn will see massive interest in Argo. Subscription based. Main market. First LSE Crypto Company. 50K (plus) on the waiting list. Very exciting & moves like lightening! Tmsb1 - google proactiveinvestors & watch the interviews with Bixby.

Crikey, I hadn’t seen that! $2.5Million a month straight out of the blocks! This is seriously undervalued & I’ll be loading again tomorrow - I’ve signed up via the Argo website & am on the waiting list too. Buying more tomoz.

On the waiting list. Assume subscription charges are £50 pa. That’s £2.5M in revenue coming aboard as soon as they have the capacity. With Crypto’s on the move this is going to get interesting pretty quickly as folk will want to be involved in the next ‘wave’. Valuations of ARB when subscribers are quickly in the hundreds of thousands?

First Blockchain Company to be listed on The LSE. The Main Market. That’s some achievement.

On Proactiveinvestors. They’ve got 50K on their waiting list. ARGO is Subscription based ( Think Netflix), this is the holy grail of any tech business.

Ringing around known holders? Surely you jest? A broker ringing someone up to buy their stock is surely the biggest signal to hold onto them. Bitcoin & other Cryptos are on the move from languishing at year lows, this is the second bounce & there is talk of a bull run coming, see previous links.

Moving quickly now. Up 4.83% now.

At 16p a share valuing the Company at £47M. Currently valued at £29M. Bitcoin & all Crypto’s suddenly starting to move up. We’ve all seen how quickly they can move, and with a quiet IPO in August ARgo is under the radar. And undervalued right now. Watch this Company grow very quickly & Main market listed too.

First session, good though!! I’m having a G&T now!! Cheers.

Thanks for the link Mike, our w/e guests have just departed - enjoying watching it live & the peace in out house. like the fact there is English translation as French a bit rusty!

Amazing Value here atm, talk about unloved!! 1. £6.9M in cash June 2018. 2. Over 60 Patents. 3 The Company is revenue generating. 4. Focussing on high value biologic drug manufacture. 5. Demand for Biologic drugs est to reach $445 Billion by 2019. 6.internal Target revenues of £17M - £19M by 2022 ( its 2019 shortly).

But without the fundraise the Company wouldn’t have been able to deliver at all. Let’s see if it has managed to bridge the gap & ‘If the plan, properly funded & executed, is expected ( big word there) to allow us to achieve positive EBITBA in 2019’ If they can ‘execute’ & the next update confirms a big order/contract expect serious retruns from these levels. However, it seems like a binary bet right now.

Who first bought at 2p on the open offer are wondering why this is tanking and deciding to bail, by the looks of it. Any sell under 2p is a loss. Wait for results & an update from the Company in 6 trading days. Easy money for the mm’s but I continue to add at these very cheap prices.

At 65p To set the trend for today.

It sounds like you’re here with an Axe to grind. Don’t you like this new technology? The Company only have to announce traction with Customers & this will move very quickly imo. It’s priced to fail right now, but let’s have an update from our US trial clients.